A survival score for patients assigned to palliative radiotherapy for metastatic bladder cancer

Dirk Rades, Lisa Manig, Stefan Janssen, Steven E. Schild

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Aim: To create a survival score for patients with metastatic bladder cancer. Patients and Methods: In 46 irradiated patients, six characteristics were evaluated for their association with survival: Age, gender, Karnofsky performance scale, initial stage (American Joint Committee on Cancer), number of metastatic sites, and interval between bladder cancer diagnosis and palliative radiotherapy. Characteristics showing a trend (p<0.15) were incorporated into the score. Six-month survival rates were divided by 10. Patients' scores were derived by totaling the scores of these characteristics. Results: Performance scale (p=0.14), stage (p=0.055) and number of metastatic sites (p=0.10) showed a trend for association with survival. Patients' scores were 6, 7, 8, 10 or 12 points, with corresponding 6-month survival rates of 20%, 0%, 0%, 46% and 45% (p=0.038). Two groups were created, with 6-8 and with 10-12 points, with 6-month survival rates of 9% and 46% (p=0.002), respectively. Conclusion: A new survival score was developed. Patients with 6-8 points should receive less aggressive treatments for metastatic bladder cancer. Those with 10-12 points may receive more intensive approaches.

Original languageEnglish (US)
Pages (from-to)1481-1484
Number of pages4
JournalAnticancer Research
Volume37
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Urinary Bladder Neoplasms
Radiotherapy
Survival
Survival Rate
Karnofsky Performance Status
Neoplasms

Keywords

  • Metastatic bladder cancer
  • Palliation
  • Personalized treatment
  • Radiotherapy
  • Survival score

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

A survival score for patients assigned to palliative radiotherapy for metastatic bladder cancer. / Rades, Dirk; Manig, Lisa; Janssen, Stefan; Schild, Steven E.

In: Anticancer Research, Vol. 37, No. 3, 01.03.2017, p. 1481-1484.

Research output: Contribution to journalArticle

Rades, Dirk ; Manig, Lisa ; Janssen, Stefan ; Schild, Steven E. / A survival score for patients assigned to palliative radiotherapy for metastatic bladder cancer. In: Anticancer Research. 2017 ; Vol. 37, No. 3. pp. 1481-1484.
@article{4c6e9f4802a043c49130075aebae903b,
title = "A survival score for patients assigned to palliative radiotherapy for metastatic bladder cancer",
abstract = "Aim: To create a survival score for patients with metastatic bladder cancer. Patients and Methods: In 46 irradiated patients, six characteristics were evaluated for their association with survival: Age, gender, Karnofsky performance scale, initial stage (American Joint Committee on Cancer), number of metastatic sites, and interval between bladder cancer diagnosis and palliative radiotherapy. Characteristics showing a trend (p<0.15) were incorporated into the score. Six-month survival rates were divided by 10. Patients' scores were derived by totaling the scores of these characteristics. Results: Performance scale (p=0.14), stage (p=0.055) and number of metastatic sites (p=0.10) showed a trend for association with survival. Patients' scores were 6, 7, 8, 10 or 12 points, with corresponding 6-month survival rates of 20{\%}, 0{\%}, 0{\%}, 46{\%} and 45{\%} (p=0.038). Two groups were created, with 6-8 and with 10-12 points, with 6-month survival rates of 9{\%} and 46{\%} (p=0.002), respectively. Conclusion: A new survival score was developed. Patients with 6-8 points should receive less aggressive treatments for metastatic bladder cancer. Those with 10-12 points may receive more intensive approaches.",
keywords = "Metastatic bladder cancer, Palliation, Personalized treatment, Radiotherapy, Survival score",
author = "Dirk Rades and Lisa Manig and Stefan Janssen and Schild, {Steven E.}",
year = "2017",
month = "3",
day = "1",
doi = "10.21873/anticanres.11473",
language = "English (US)",
volume = "37",
pages = "1481--1484",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3",

}

TY - JOUR

T1 - A survival score for patients assigned to palliative radiotherapy for metastatic bladder cancer

AU - Rades, Dirk

AU - Manig, Lisa

AU - Janssen, Stefan

AU - Schild, Steven E.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Aim: To create a survival score for patients with metastatic bladder cancer. Patients and Methods: In 46 irradiated patients, six characteristics were evaluated for their association with survival: Age, gender, Karnofsky performance scale, initial stage (American Joint Committee on Cancer), number of metastatic sites, and interval between bladder cancer diagnosis and palliative radiotherapy. Characteristics showing a trend (p<0.15) were incorporated into the score. Six-month survival rates were divided by 10. Patients' scores were derived by totaling the scores of these characteristics. Results: Performance scale (p=0.14), stage (p=0.055) and number of metastatic sites (p=0.10) showed a trend for association with survival. Patients' scores were 6, 7, 8, 10 or 12 points, with corresponding 6-month survival rates of 20%, 0%, 0%, 46% and 45% (p=0.038). Two groups were created, with 6-8 and with 10-12 points, with 6-month survival rates of 9% and 46% (p=0.002), respectively. Conclusion: A new survival score was developed. Patients with 6-8 points should receive less aggressive treatments for metastatic bladder cancer. Those with 10-12 points may receive more intensive approaches.

AB - Aim: To create a survival score for patients with metastatic bladder cancer. Patients and Methods: In 46 irradiated patients, six characteristics were evaluated for their association with survival: Age, gender, Karnofsky performance scale, initial stage (American Joint Committee on Cancer), number of metastatic sites, and interval between bladder cancer diagnosis and palliative radiotherapy. Characteristics showing a trend (p<0.15) were incorporated into the score. Six-month survival rates were divided by 10. Patients' scores were derived by totaling the scores of these characteristics. Results: Performance scale (p=0.14), stage (p=0.055) and number of metastatic sites (p=0.10) showed a trend for association with survival. Patients' scores were 6, 7, 8, 10 or 12 points, with corresponding 6-month survival rates of 20%, 0%, 0%, 46% and 45% (p=0.038). Two groups were created, with 6-8 and with 10-12 points, with 6-month survival rates of 9% and 46% (p=0.002), respectively. Conclusion: A new survival score was developed. Patients with 6-8 points should receive less aggressive treatments for metastatic bladder cancer. Those with 10-12 points may receive more intensive approaches.

KW - Metastatic bladder cancer

KW - Palliation

KW - Personalized treatment

KW - Radiotherapy

KW - Survival score

UR - http://www.scopus.com/inward/record.url?scp=85015952258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015952258&partnerID=8YFLogxK

U2 - 10.21873/anticanres.11473

DO - 10.21873/anticanres.11473

M3 - Article

C2 - 28314321

AN - SCOPUS:85015952258

VL - 37

SP - 1481

EP - 1484

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3

ER -